Nanoemulsions as vehicles for transdermal delivery of aceclofenac

AAPS PharmSciTech

Volumn 8, Issue 4, 2007, Pages

  Shakeel, Faiyaz ^a   Baboota, Sanjula ^a   Ahuja, Alka ^a   Ali, Javed ^a   Aqil, Mohammed ^a   Shafiq, Sheikh ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Aceclofenac; Anti inflammatory effects; Nanoemulsions; Transdermal delivery

Indexed keywords

ACECLOFENAC; CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; DRUG VEHICLE; LABRASOL; MYRISTIC ACID ISOPROPYL ESTER; OCTANOIC ACID DERIVATIVE; OLEIC ACID; OLIVE OIL; POLYSORBATE 80; TRIACETIN; CARRAGEENAN; DICLOFENAC; DRUG CARRIER; DRUG DERIVATIVE; EXCIPIENT; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; OIL; WATER;

ABDOMEN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; EMULSION; GEL; IN VITRO STUDY; MALE; NANOTECHNOLOGY; NONHUMAN; PAW EDEMA; RAT; REFRACTION INDEX; SKIN IRRITATION; SKIN PERMEABILITY; STEADY STATE; THERMODYNAMICS; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DIFFUSION CHAMBER; DISEASE MODEL; DRUG EFFECT; EDEMA; INTRADERMAL DRUG ADMINISTRATION; KINETICS; METABOLISM; METHODOLOGY; MOUSE; PARTICLE SIZE; PERMEABILITY; PHARMACEUTICS; SKIN; SKIN ABSORPTION; SURFACE PROPERTY; TEMPERATURE; TOXICITY TESTING; WISTAR RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DIFFUSION CHAMBERS, CULTURE; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; EDEMA; EMULSIONS; EXCIPIENTS; KINETICS; MALE; MICE; NANOPARTICLES; OILS; PARTICLE SIZE; PERMEABILITY; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; SKIN IRRITANCY TESTS; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; VISCOSITY; WATER;

EID: 37349108788     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0804104     Document Type: Article

References (36)

1. Escribano E, Calpena AC, Queralt J, Obach R, Domenech J. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci. 2003;19:203-210.
2. Yamazaki R, Kawai S, Mastsuzaki T, et al. Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygcnase inhibitors. Eur J Pharmacol. 1997;329:181-187.
3. Gonzalez E, Cruz C, Nicolas R, Egido J, Herrero-Beaumont G. Long-term effects of nonstcroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions. 1994;41:171-178.
4. Yang JH, Kim Y, Kim KM. Preparation and evaluation of aceclofenac microemulsion for transdermal delivery system. Arch Pharm Res. 2002;25:534-540.
5. Walters KA. Penetration enhancers and their use in transdermal therapeutic systems. In: Hadgraft J, Guy RH, eds. Transdermal Drug Delivery, Developmental Issues and Research Initiatives. New York, NY: Marcel Dekker; 1989:197-246.
6. Shafiq S, Faiyaz S, Sushma T, Abroad FJ, Khar RK, Ali M. Design and development of oral oil in water ramipril nanoemulsion formulation: in vitro and in vivo evaluation. J Biomed Nanotech. 2007;3:28-44.
7. Shafiq S, Faiyaz S, Sushma T, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66:227-243.
8. Osborne DW, Ward AJ, Neil KJ. Microemulsions as topical delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol. 1991;43:450-454.
9. Trotta M, Pattarino F, Gasco MR. Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm Acta Helv. 1996;71:135-140.
10. Delgado-Charro MB, Iglesias-Vilas G, Blanco-Mendez J, Lopez-Quintela MJ, Marty MA, Guy JP. Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur J Pharm Biopharm. 1997;43:37-42.
11. Dreher F, Walde P, Walter P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Rel. 1997;45:131-140.
12. Schmalfus U, Neubart R, Wohlrab W. Modification of drug penetration into human skin using microemulsions. J Control Rel. 1997;46:279-285.
13. Kreilgaard M, Pedersen EJ, Jaroszewski JW. NMR characterization and transdermal drug delivery potentials of microemulsion systems. J Control Rel. 2000;69:421-433.
14. Alvarez-Figueroa MJ, Blanco-Mendez J. Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm. 2001;215:57-65.
15. Rhee YS, Choi JG, Park ES, Chi SC. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm. 2001;228: 161-170.
16. Lee PJ, Langer R, Shastri VP. Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res. 2003;20:264-269.
17. Kemken J, Ziegler A, Muller BW. Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle. Pharm Res. 1992;9:554-558.
18. Kreilgaard M. Dermal pharmacokinetics of microemulsion formulations determined by in-vitro microdialysis. Pharm Res. 2001; 18: 367-373.
19. Kreilgaard M, Kemme MJB, Burggraaf J, Schoemaker RC, Cohen AF. Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics. Pharm Res. 2001;18:593-599.
20. Ktistis G, Niopas I. A study on the in-vitro percutaneous absorption of propranolol from disperse systems. J Pharm Pharmacol. 1998;50: 413-419.
21. Gasco MR, Gallarate M, Pattarino F. In vitro permeation of azelaic acid from viscosized microemulsions. Int J Pharm. 1991;69:193-196.
22. Kriwet K, Muller-Goymann CC. Diclofenac release from phospholipid drug systems and permeation through excised human stratum comeum. Int J Pharm. 1995;125:231-242.
23. Trotta M. Influence of phase transformation on indomethacin release from microemulsions. J Control Rel. 1999;60:399-405.
24. Baboota S, Shakeel F, Kohli K. Formulation and evaluation of once a day transdermal gels of diclofenac diethylamine. Methods Find Exp Clin Pharmacol. 2006;28:109-114.
25. Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech [serial online]. 2007;8:E28.
26. Attwood D, Mallon C, Ktistis G, Taylor CJ. A study on factors influencing the droplet size in nonionic oil-in-water microemulsions. Int J Pharm. 1992;88:417-422.
27. Van-Abbe NJ, Nicholas P, Boon E. Exaggerated exposure in topical irritancy and sensitization testing. J Soc Cosmet Chem. 1975;26: 173-187.
28. Winter CA. Anti-inflammatory testing methods: comparative evaluation of indomethacin and other agents. Nonsteroid Anti-inflammat Drugs. 1965;52:190-202.
29. Gosh MN. Fundamentals of Experimental Pharmacology. Kolkata, India: Hilton and Company; 2005:192.
30. Craig DQM, Barker SA, Banning D, Booth SW. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm. 1995; 114: 103-110.
31. Eccleston J. Microemulsions. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. vol. 9. New York, NY: Marcel Dekker; 1995:375-421.
32. Kawakami K, Yoshikawa T, Moroto Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs, I: prescription design. J Control Rel. 2002;81:65-74.
33. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89-121.
34. Warisnoicharoen W, Lansley AB, Lawrence MJ. Light scattering investigations on dilute non-ionic oil-in-water microemulsions. AAPS PharmSciTech [serial online]. 2002;2:E12.
35. Li P, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin ATM. Effect of combined use of nonionic, surfactant on formation of oil-in-water microernulsions. Int J Pharm. 2005;288:27-34.
36. Shinoda K, Kunieda H. Phase properties of emulsions: PIT and HLB. In: Schuster D, ed. Encyclopedia of Emulsion Technology. New York, NY. Marcel Dekker; 1983:337-367.